baber/WOPTO huggingface dataset:
Patent DK-161504-B (DK)
Inventor: RITZL ANTAL
IPC: B61D25/00
Filed: 1987-02-03
Abstract: 1. Outer shell of vehicles, in particular for conveying people by rail and road, having window glazing (34) which can be adjusted so as to be in exact alignment and is held by means of window frame profiles (14) secured releasably on the side-wall (10) and the pillar profiles (76), characterized by means (20) for anchoring the window frame profiles (14) on the side-wall or pillar profiles (76), which means can be adjusted in length by a rotary movement and, following the adjustement, are mounted secure against twisting.
Patent HU-192668-B (HU)
Title: Process for preparing 15alpha-hydroxy-4-androstene-3,17-dione
Inventor: PETZOLDT KARL
IPC: C07J1/00
Filed: 1985-02-01
Abstract: 1. Process for the manufacture of 15 alpha-hydroxy-4-androstene-3,17-dione by the microbiological hydroxylation of 4-androstene-13,17-dione characterised in that Penicillium stoloniferum CBS P 102, Penicillium melinii CBS P 30 or Fusarium oxysporum f. vasinfectum ATCC 7808 are used for the fermentation.
Patent HU-191218-B (HU)
Title: Process for preparing wood concrete blocks with coating curable by electronic radiation
Inventor: FUHR KARL
IPC: C08F2/46
Filed: 1984-02-02
Abstract: Primer contains (a) a pre-polymer with (meth)acryloyl gps., and (b) (in)organic fibres with a max. of the fibre length distribution curve at 50-600 microns. - (a) Pref. contains 20-80 wt.% of a polyester-, polyepoxy- or polyurethane-(meth)acrylate, and 80-20% of reactive, radiation hardening monomer(s), e.g. (meth)acrylate esters of aliphatic mono-, di- or tri-ols or their alkoxylation prods. contg. 0.8-4 alkylene oxide, e.g. ethylene oxide (pref.) or propylene oxide w.r.t. 1 OH gp. in the alcohol. Acrylates of (alkoxylated) di-or tri-ols are pref.. - Its use is on absorbent substrates. Wood/concrete mouldings carrying a layer of the primer, and a top coating, are claimed. Few layers (pref. 1) of primer and top coat are needed. Reproducible, permanent coatings are obtd., protecting wood against damage in transport and use.(0/0)
Patent HU-197291-B (HU)
Title: Process for producing dicarboxylic acid esters
Inventor: SZIJJARTO ENDRE
IPC: C07C69/34
Filed: 1985-02-15
Abstract: Prods. ROOC-(CH2)n-X-(CH2)m-COOR (I) are prepd. by reacting a dinitrile NC-(CH2)n-X-(CH2)m-CN (II) with an alcohol R-OH (III). In the formulae, R stands for alkyl with 8-18 carbons, the two R gps. in formula (I) may be identical or different, X is oxygen, sulphur or methylene, m and n are independently 1, 2 or 3. - Reaction is carried out in the presence of 0.025-0.1 mole of an alcohol with 1-6 carbons, of 1.3-3.0 mole sulphuric-acid and 4-15 mole water for 1 mole of dinitrile of general formula (II).
Patent LT-4311-B (LT)
Title: N-{4-[bis(2-chlorethyl)amino]phenylacetyl}-l-phenylalanin, method for preparing thereof, pharmaceutical composition and pharmaceutical formulation
Inventor: PUODZIUNAITE BENEDIKTA-DALE
IPC: C07C229/28
Filed: 1996-06-27
Abstract: This invention belongs to the branch of pharmaceutical chemistry, it is namely used for producing remedy N-{4-[bis(2-chlorethyl)amino]phenyl acetyl} -L-alanine and the product phenalon, the formula of which is <IMAGE>, the method for producing a compound which has this pharmaceutical composition and form of medicine. The production method described in this invention ensures the extrication and purification of active material of the remedy - phenalon. The invention also describes the pharmaceutical composition and form of medicine - tablets, which weigh 300 mg and correspond to the requirements of pharmacology. The main indications when treating patients with phenalon are hemoblastosis: malignant lymphomas (both Hodzhkin and non-Hodzhkin), lymphoepithelioma, chronic lymph-leucosis, melomical disease, Kaposi's sarcoma and some solid tumours - seminoma, ovarian cancer.
Patent MT-P1063-B (MT)
Title: Plasmids,their construction and their use in the manufacture of a plasminogen activator
IPC: C12N15/58
Filed: 1990-06-28
Abstract: Plasmids with synthetic DNA sequences, which are suitable for expressing a precursor protein of rscu-PA (that is to say the unglycosylated protein portion of the single-chain prourokinase) in Enterobacteriaceae, especially E. coli, in an amount which is considerably above the yields which can be achieved using plasmids of the state of the art, are described. The plasmids according to the invention are characterised in that their operon has a controllable, optionally synthetic promoter, a Shine-Dalgarno sequence, a start codon, a synthetic structural gene and, downstream from the structural gene, at least one terminator. The preparation of the plasmids and of the synthetic DNA sequences starting from commercially available plasmids etc. is described. The precursor protein of rscu-PA which is expressed at a high rate using them can be refolded in a manner known per se to give the rscu-PA which can be employed therapeutically as plasminogen activator and which can then, if required, also be employed for cleavage, which is carried out in a manner known per se, to obtain the two-chain unglycosylated urokinase protein (rtcu-PA) on the industrial scale. <IMAGE>
Patent NO-133865-B (NO)
Inventor: STARON T J
IPC: A23J1/12
Filed: 1971-03-03
Abstract: Fremgangsmåte til avgiftning av vegetabilske presskaker.
Patent YU-46489-B (YU)
Inventor: CARUSO M
IPC: C07C225/34
Filed: 1989-05-08
Abstract: Anthracycline glycosides of formula (I) and their pharmaceutically acceptable acid addn. salts are new where R1 = H or OH; one of R2 and R3 = H, the other is H or OH. Also new are the intermediates 4-demethoxy-4-amino -7-deoxy-daunomycinone (IX) and daunomycinones (II), opt. N-protected. - (I) is pref. 4-demethoxy-4 -amino-daunorubicin; 4-demethoxy- 4-amino-4'-epi-daunorubicin or 4-demethoxy-4-amino -4'-deoxy-daunorubicin, and the corresp. doxorubicin cpds.
Patent AT-399772-B (AT)
Title: Combustion-chamber shaft of a water heater
IPC: F24H9/00
Filed: 1992-06-29
Granted: 1995-07-25
Abstract: Combustion-chamber shaft 1 of a water heater, with a heat exchanger 2 mounted thereon, in which the combustion- chamber shaft is designed as a double jacket, through which a medium to be heated flows, and the interior of the double jacket is connected to the heat exchanger. The combustion-chamber shaft 1 consists of die-cast mouldings 10, 11, on which functional parts, such as connections 3, 3', an inspection-glass holder and the like, are integrally formed in one piece. <IMAGE>
Patent AT-390141-B (AT)
Title: Heat exchanger, in particular for vapourizing the refrigerant (evaporant, cryogen) of a heat pump
IPC: F25C1/145
Filed: 1988-08-19
Granted: 1990-03-26
Abstract: In order to be able to make use in a simple way for the purpose of vapourizing the refrigerant of a heat pump of the heat released when water freezes, a heat exchanger is proposed which has a heat transfer wall 5 between the refrigerant and water. Said wall is assigned a spraying device 8, connected to a water source, for the surface facing the refrigerant, which forms a runway for at least one roller body 12 for removing the incipiently freezing water. <IMAGE>
Patent AT-396862-B (AT)
IPC: D01F1/10
Filed: 1991-10-22
Granted: 1993-12-27
Abstract: Described are methods of manufacturing a cellulose-acetate bundle, the filaments making up the bundle being produced by extruding a solution containing, in addition to cellulose-(2,5)-acetate and solvent, non-toxic compounds which are only slightly soluble in the solution and whose molecular diameter is at least 30 % less than the diameter of the filaments. Water-soluble or bacteriologically degradable organic compounds, in particular starch, starch derivatives or dextrins, are used as the additives.
Patent AT-391917-B (AT)
Title: Method of repairing drains or sewers
Inventor: HAYDEN RUDOLF DIPL ING
IPC: E03F3/06
Filed: 1987-10-06
Granted: 1990-12-27
Abstract: Method of repairing drains or sewers of any cross section which can be entered by crawling or on foot and the load- bearing capability of which is at risk, in which method an impermeable inner form work is inserted into the damaged drain or sewer, then preferably rotatable inserts with nozzles are fitted in specially prepared recesses in the form work wall and are connected by means of a pressure hose to a mixing and pumping system or outflow lines for the removal of the flushed material, whereupon the damaged in-situ material, including the organic impurities, is detached and or removed with the aid of cutting jets of water or suspension and the cavity produced as a result or already existing is filled with suspension and solidified.
Patent FI-77645-B (FI)
Inventor: SKUBALLA WERNER
IPC: C07C405/00
Filed: 1983-07-13
Granted: 1988-12-30
Abstract: Carbacylin derivatives of the general formula I <IMAGE>  in which   R1 denotes a hydrogen atom or the radical OR2, in which R2 can denote hydrogen, alkyl, cycloalkyl, aryl, the radical <IMAGE> or a heterocyclic radical, or R1 can denote the radical NHR3 where R3 denotes an acid radical or the radical R2, n can denote the number 2, 3, 4 or 5, X denotes a hydrogen atom or a fluorine atom,    A denotes a -CH2-CH2-, a trans -CH=CH- or -C IDENTICAL C- group,   W denotes a free or functionally modified hydroxymethylene group or a free or functionally modified <IMAGE> group, in which the OH group can be in the  alpha  or  beta position,    D denotes the group <IMAGE> a straight-chain, saturated alkylene group having 1-5 C atoms, a branched saturated or a straight-chain or branched unsaturated alkylene group having 2-5 C atoms, which may be substituted by fluorine atoms,    m can denote the number 1, 2 or 3,   E represents a direct bond, a -C IDENTICAL C- group or a -CR6=CR7- group, in which R6 denotes a hydrogen atom or an alkyl group having 1-5 C atoms and R7 denotes a hydrogen atom, an alkyl group having 1-5 C atoms or a halogen atom,   R4 denotes an alkyl, cycloalkyl or a substituted or unsubstituted aryl group or a heterocyclic group,    R5 denotes a free or functionally modified hydroxyl group, and, if R2 denotes a hydrogen atom, the salts thereof with physiologically acceptable bases, a process for their preparation and their use as pharmaceuticals.
Patent FI-82188-B (FI)
Inventor: PANDIT NEVEDITA
IPC: A61K31/00
Filed: 1984-03-14
Granted: 1990-10-31
Abstract: Water-soluble dispersions of chlorthalidone are prepared by a process comprising: (a) forming a solution comprising a water soluble pharmaceutically acceptable polymeric carrier and a C1-C4 alkanol,  (b) dissolving chlorthalidone in the solution thus formed, and  (c) removing the C1-C4 alkanol from the solution by evaporation, the amount of said carrier being effective to suppress substantially the formation of the alkyl ether by-product from the reaction of chlorthalidone with the C1-C4 alkanol. A preferred water soluble carrier is polyvinylpyrrolidon and a preferred C1-C4 alkanol is methanol.
Patent FI-81113-B (FI)
Inventor: KOLLER KLAUS-PETER
IPC: C07K7/08
Filed: 1985-05-15
Granted: 1990-05-31
Abstract: 1. Claims for the contracting states : BE. CH. LI. DE. FR. GB. IT. LU. NL. SE DNA sequence B, obtainable from Streptomyces tendae strains, which produce tendamistat and have preferably been treated with sublethal doses of acriflavine, by isolation of the complete DNA, digestion with Pst l, Southern hybridization with the DNA sequence A, 5'-(**32 P-)CCT TCA GTG TCG TCT TCG TA-3' (A) isolation of the 2.3 kb Pst l fragment, cutting with BamHl, Southern hybridization with the sequence A, isolation of the 0.94 kb Pst l-BamHl subfragment, cutting with Sau 3a, Southern hybridization with the sequence A, isolation of the 0.525 kb BamHi-Sau 3a subfragment and sequencing of the DNA, and which has the following features : a) it is located immediately upstream of the tendamistat structural gene, b) it codes at the amino terminal end for Met-Arg-Val-Arg-Ala-Leu-Arg, c) it codes at the carboxyl terminal end for Ala-Ser-Ala and d) it codes in the middle for a hydrophobic region X which comprises 10 to 25, preferably 17 to 20, amino acids. 1. Claims for contracting state AT A process for the preparation of polypeptides composed of genetically codable amino acids, characterized by the expression, in a host cell of the genus Streptomyces, of a gene structure which contains in the reading frame with the structural gene for the desired polypeptide the DNA sequence B of a prepeptide, which sequence is obtainable from Streptomyces tendae strains, which produce tendamistat and have preferably been treated with sublethal doses of acriflavine, by isolation of the complete DNA, digestion with Pst l, Southern hybridization with the DNA sequence A, 5'-(**32 P-)CCT TCA GTG TCG TCT TCG TA-3' (A) isolation of the 2.3 kb Pst l fragment, cutting with BamHI, Southern hybridization with the sequence A, isolation of the 0.94 kb Pst l-BamHl subfragment, cutting with Sau 3a, Southern hybriridization with the sequence A, isolation of the 0.525 kb BamHl-Sau 3a subfragment and sequencing of the DNA, and a) is located immediately upstream of the structural gene, b) codes at the amino terminal end for Met-Arg-Val-Arg-Ala-Leu-Arg, c) codes at the carboxyl terminal end for Ala-Ser-Ala and d) codes in the middle for a hydrophobic region X which comprises 10 to 25 amino acids.
Patent FI-91413-B (FI)
Inventor: RIVIER CATHERINE LAURE
IPC: C07K1/02
Filed: 1985-10-22
Granted: 1994-03-15
Abstract: Agonists of rCRF and oCRF are disclosed that can be administered to achieve a substantial elevation of ACTH. ß-endorphin, ß-lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or a lowering of blood pressure over an extended period of time. One agonist which has been found to be particularly potent is: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH<sub>2</sub>. In the agonists, one or more of the first five N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and cr by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain. Similar peptides which function as CRF antagonists are ceated by deleting the first 7, 8 or 9 N-terminal residues. These analogs or pharmaceuncally or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier can be administered to mammals, including humans The agonists may also be used as stimulants to elevate mood and improve memory and teaming, as well as diagnostically. The antagonists can be used to lower stress.
Patent FI-85870-B (FI)
Inventor: DE KONING ADRIANUS JOHANNES
IPC: C08F222/40
Filed: 1986-06-05
Granted: 1992-02-28
Abstract: The invention relates to a composition comprising(A) 64-4 parts by wt. of a bismaleimide compound, or an isomaleimide isomer thereof, a maleimide-amide compound or an isomaleimide isomer thereof and maleic anhydride compound,(B) 7-77 parts by wt. of one or more ethylenically unsaturated compounds containing 5-50 C-atoms and is characterised in that the composition further comprises(C) 3-60 parts by wt. of one or more compounds from the group of hydroxy-alkylacrylates or amino-alkylacrylates,(D) 1-20 parts by wt. of one or more terminally functional polymers as flexibilizer, with the proviso that the sum, of parts of compounds A, B, C and D amounts to 100.
Patent FI-87223-B (FI)
Inventor: BOSIES ELMAR
IPC: C07F9/6536
Filed: 1987-07-31
Granted: 1992-08-31
Abstract: The present invention produces alkyldiphosphonic acid derivative of the general formula:    <IMAGE>  (I)  wherein Het is a heteroaromatic five-membered ring containing to 3 heteroatoms which can be partly hydrogenated and optionally substituted one or more times by alkyl, alkoxy, phenyl, cyclohexyl, cyclohexylmethyl, halogen or amino, and two adjacent alkyl substituents can together also form a ring, Y is a hydrogen atom or a lower alkyl radical, X is a hydrogen atom, a hydroxyl group or an amino group optionally substituted by lower alkyl and R is a hydrogen atom or a lower alkyl radical, with the proviso that Het is not a pyrazole ring; as well as the pharmacologically acceptable salts thereof. The present invention also provides processes for the prepearation of these compounds and pharmaceutical compositions containing them useful for the treatment or prophylaxis of calcium metabolism disturbances or disease as for example osteoporosis, Bechterew's disease, bone metastases, urolithiasis, heterotropic ossifications, rheumatoid arthritis osteoarthritis or degenerative arthrosis.
Patent FI-86661-B (FI)
Inventor: SVENSSON GUNNAR
IPC: E04B1/61
Filed: 1988-04-15
Granted: 1992-06-15
Abstract: A connection assembly primarily for so-called air treatment apparatus housing slabs (1), the edges of the slabs (1) which are to be connected being provided with support sections (2). Each support section (2) has edge portion legs (12,25), a joining web (6) and a squeezing leg (7) substantially at right angles thereto, the leg being terminated by an abutment end (8), and having a length ( ) corresponding to approximately half the depth (L) of the slab or support section. The edge portion is U-shaped with two legs, one (25) of which being attached to the adjacent slab and one (12) being free with a gap (26) therebetween. The web (4) of the connection section (3) in a position of use is flush with one flat face (22) of the slab (1) or at a level which is parallel to this face. Locking legs (5) depart from the edges of the web (4) and with the aid of stiffening bends (9, 10) engage and retain in the connection position the abutment ends (8) of the support sections (2). The connection section (3) engages against the legs (12) of edge portions and/or with the adjacent major surface (22) of the slabs (1) with external engagement surfaces (13).
Patent FI-93856-B (FI)
Inventor: MILES RICHARD
IPC: C10L1/14
Filed: 1988-05-06
Granted: 1995-02-28
Abstract: Improved gasoline compositions containing a minor amount of a polyalphaolefin having a viscosity at 100 DEG C from 2 to 20 centistokes, and optionally also an aliphatic polyamine, an alkali or alkaline earth metal salt of a succinic acid derivative, and/or a polyolefin; together with a concentrate for the production of such gasoline composition and a method of operating a spark-ignition engine using such gasoline composition.
Patent FI-96772-B (FI)
Inventor: VROOMANS HUBERTUS JOHANNES
IPC: C08L57/00
Filed: 1988-11-01
Granted: 1996-05-15
Abstract: The invention concerns a thermoplastic polymer mixture based on a polyamide and a graft copolymer of a copolymer of a vinyl aromatic compound and acrylonitrile in a rubber, on the rubber being moreover present monomers of a vinylaromatic compound and of a carboxy- and/or imide-containing compound in a relative molar ratio of 5 : 1 to 1 : 5. It was found that the mixture of both components showed superior mechanical properties, and is easy to process.
Patent FI-95599-B (FI)
Title: Acyloxyacyl hydrolase and the use thereof
Inventor: MUNFORD ROBERT S
IPC: C12N/
Filed: 1988-11-24
Granted: 1995-11-15
Abstract: An acyloxyacyl hydrolase from the human promyelocyte cell line HL-60 has been found to specifically hydrolyze fatty acids from their ester linkages to hydroxy groups of 3-hydroxyfatty acids, the latter being bound in turn to LPS glycosaminyl residues. The hydrolyzed fatty acids may include dodecanoic acid, tetradecanoic acid and hexadecanoic acid. This enzyme showed a molecular weight by gel exclusion chromatography between about 50,000 Daltons and about 70,000 Daltons. Altered bacterial LPS substantially without fatty acids bound in ester linkage to hydroxy groups of 3-hydroxyfatty acids covalently linked to a glucosaminyl moiety of LPS lipid A are produced. Since the structure of the lipid A moiety is highly conserved, acyloxyacyl hydrolase may act on LPS of many different pathogenic bacteria (for example Salmonella, Escherichia, Hemophilus, and Neisseria). Such altered bacterial LPS, having toxicity reduced more than immunostimulatory activity, may be therapeutically useful: (1) as vaccines to prevent Gram-negative bacterial diseases by inducing antibodies to LPS 0-polysaccharide or R-core antigens, (2) as antidotes to treat or prevent Gram-negative bacterial sepsis ("septic shock"), or (3) as adjuvants to enhance formation of antibodies to other antigens. The acyloxyacyl hydrolase itself may be prophylactically or therapeutically useful to detoxify endogenous LPS in patients with Gram-negative bacterial diseases. The enzyme may also be used to remove toxic LPS from therapeutic injectants.
Patent FI-96035-B (FI)
Inventor: VON GENTZKOW WOLFGANG
IPC: C08G59/00
Filed: 1990-03-02
Granted: 1996-01-15
Abstract: Epoxy resin moulding compositions for sheathing semiconductor components which are inexpensive to produce and have good processing properties give, without addition of flameproofing agents, flame-resistant moulded materials of high glass transition temperature and low thermal expansion coefficient if they contain the following components: (A) a phosphorus-free aromatic and/or heterocyclic polyepoxy resin, optionally blended with an aliphatic epoxy resin,  (B) an epoxide-containing phosphorus compound,  (C) an aromatic polyamine as curing agent, and (D) fillers. t
Patent FI-93006-B (FI)
Inventor: BADGER ALISON MARY
IPC: C07D/
Filed: 1990-03-27
Granted: 1994-10-31
Abstract: The invention relates to pharmaceutical compositions containing immunomodulatory azaspiranes of the formulae (I) and (II): <CHEM> wherein n is 3-7, m is 1 or 2, and R<1> to R<6> are hydrogen or alkyl. Also disclosed are novel azaspiranes and processes for their preparation.
Patent FI-94430-B (FI)
Inventor: TUOVINEN FRANS HEIKKI
IPC: C22B19/04
Filed: 1993-01-26
Granted: 1995-05-31
Abstract: The invention relates to a method for utilizing zinciferous waste from metal smelters, such as steel smelters, so that the transmission of fluorides to the highly zinciferous secondary dusts is prevented during the treatment of the gas obtained from the waste smelting furnace. Fluorides are extremely harmful for the zinc process, and therefore it is important to prevent them from entering the process. By adjusting, according to the invention, the temperature and composition of the exhaust gases created in the smelting treatment of zinciferous dusts and other waste, the fluorides and the highly zinciferous fraction are obtained in different end products. Other valuable metals are recovered from the metal layer created on the bottom of the furnace.
Patent FI-109806-B (FI)
Inventor: SULLIVAN WILLIAM J
IPC: C09C1/42
Filed: 1993-10-18
Granted: 2002-10-15
Abstract: Iron oxide-coated micaceous pigments having a chroma enhancing amount of a coating of a colorless metal oxide which has a refractive index of at least about 2.0 exhibit intensely colored effects.
Patent FI-105464-B (FI)
Inventor: TURUNEN ISMO
IPC: B65H18/26
Filed: 1996-06-10
Granted: 2000-08-31
Abstract: A method and device for winding a material or fibrous web, wherein a number of separate web rolls are formed around separate roll cores placed one after another and side by side, while being supported by support members and loaded by a load of rider rolls in rider roll units in a truncated rider roll unit. During disturbed winding situations when the web roll separate from the winding rolls, the attachment of the rider roll unit/units to the rider roll beam is changed so that the rider rolls load the web rolls that are in a disturbed movement with a load substantially higher than the rider roll load during normal winding.
Patent FI-119377-B (FI)
Inventor: JOSIC DJURO
IPC: C07K1/30
Filed: 1997-08-22
Granted: 2008-10-31
Abstract: PCT No. PCT/EP96/00636 Sec. 371 Date Nov. 26, 1997 Sec. 102(e) Date Nov. 26, 1997 PCT Filed Feb. 14, 1996 PCT Pub. No. WO96/27003 PCT Pub. Date Sep. 6, 1996A process for the preparation of factor IX from a biological source by chromatography involves prior treatment with ammonium sulfate as a protein precipitant at a concentration of from 1.5-2.3 mol/l.